Immix Biopharma, Inc.IMMXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-38.07%
↑ 67% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-116.97%
Historical baseline
PeriodValue
2024-38.07%
2023-54.20%
2022-365.90%
2021-292.92%
202049.24%
20190.00%